Edition:
United Kingdom

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

296.76USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$296.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,485
52-wk High
$304.28
52-wk Low
$209.13

Latest Key Developments (Source: Significant Developments)

Bio Rad Laboratories Says KPMG Notified Senior Management It Required More Time To Complete Audit Of 2017 Financial Statements
Friday, 16 Mar 2018 

March 16 (Reuters) - Bio Rad Laboratories Inc ::BIO RAD LABORATORIES - KPMG NOTIFIED SENIOR MANAGEMENT IT REQUIRED MORE TIME TO COMPLETE AUDIT OF 2017 FINANCIAL STATEMENTS - SEC FILING.BIO RAD LABORATORIES SAYS UNABLE TO FILE 2017 FORM 10-K BY EXTENDED FILING DEADLINE OF MARCH 16.BIO RAD LABORATORIES SAYS IDENTIFIED CERTAIN INTERNAL CONTROL DEFICIENCIES ARISING FROM APRIL 2017 ERP SYSTEM & BUSINESS STRUCTURE CONVERSION.BIO RAD LABORATORIES - CONCLUDED THAT INTERNAL CONTROL OVER FINANCIAL REPORTING WAS NOT EFFECTIVE AS OF DEC 31, 2017.  Full Article

Bio-Rad Q4 Earnings Per Share $2.32
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $2.32.Q4 SALES ROSE 8.6 PERCENT TO $620.4 MILLION.‍FOR FULL YEAR 2018, COMPANY ANTICIPATES CURRENCY NEUTRAL REVENUE GROWTH OF APPROXIMATELY 3.5 PERCENT TO 4.0 PERCENT ​.‍FOR FULL YEAR 2018, ANTICIPATES IMPROVED PROFITABILITY WITH CURRENCY NEUTRAL OPERATING MARGIN TARGET OF 10 PERCENT​.  Full Article

Bio-Rad Authorizes New $250 Million Share Repurchase Program
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Bio Rad Laboratories Inc ::BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM.BIO RAD LABORATORIES INC - ‍NEW SHARE REPURCHASE PROGRAM SUPERSEDES COMPANY'S PRIOR SHARE REPURCHASE PROGRAM​.  Full Article

Bio Rad Laboratories reports Q3 earnings per share $0.91
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Bio Rad Laboratories Inc :Bio Rad Laboratories Inc reports third-quarter 2017 financial results.Q3 earnings per share $0.91.Q3 sales $535 million versus I/B/E/S view $508 million.Sees q4 2017 sales $615 million to $625 million.Q3 earnings per share view $0.38 -- Thomson Reuters I/B/E/S.  Full Article

Bio Rad Laboratories reports Q2 profit $0.61 per share
Wednesday, 3 Aug 2016 

Bio Rad Laboratories Inc : Second-Quarter reported revenues were $516.8 million, an increase of 2.1 percent . Bio-Rad reports second-quarter 2016 financial results .Net income for Q2 of 2016 was $18.0 million, or $0.61 per share.  Full Article

BRIEF-Bio-Rad Q1 Earnings Per Share $21.77

* Q1 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S